WuXi Biologics block fetches HK$6.1bn
WuXi Biologics Holdings has raised HK$6.1bn ($787.5m) after selling a block of shares in WuXi Biologics (Cayman), the fourth time it has trimmed its position in the company this year.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: